Harmonising IV Oxycodone with Paediatric Perioperative Medications: A Compatibility Study Through Y-Type Connectors

References

• Marsilio NR, Silva D, Bueno D. [Drug incompatibilities in the adult intensive care unit of a university hospital] Incompatibilidades medicamentosas em centro de tratamento intensivo adulto de um hospital universitário. Rev Bras Ter Intensiva. 2016;28(2):147–153. doi:10.5935/0103-507x.20160029
   PubMedGoogle Scholar
• Johanna IW, Marilyn IR, Amanda W, Dave P. Errors in the administration of intravenous medications in hospital and the role of correct procedures and nurse experience. BMJ Qual Saf. 2011;20(12):1027. doi:10.1136/bmjqs-2011-000089
   PubMed Web of Science ®Google Scholar
• Adam S, Michela C, Janine C, Michelle R, Tom S, Emma W. Incidence and prevalence of intravenous medication errors in the UK: a systematic review. Eur J Hosp Pharm. 2020;27(1):3. doi:10.1136/ejhpharm-2018-001624
   PubMedGoogle Scholar
• Pergolizzi J, Seow-Choen JV, Wexner F, Zampogna SD, Raffa G. Perspectives on intravenous oxycodone for control of postoperative pain. Pain Pract. 2016;16(7):924–934. doi:10.1111/papr.12345
   PubMed Web of Science ®Google Scholar
• Raff M, Belbachir A, El-Tallawy S, et al. Intravenous oxycodone versus other intravenous strong opioids for acute postoperative pain control: a systematic review of randomized controlled trials. Pain Ther. 2019;8(1):19–39. doi:10.1007/s40122-019-0122-4
   PubMed Web of Science ®Google Scholar
• Halliwell R. Patient-controlled analgesia. In: Acute Pain Management: Scientific Evidence. 5th Edition ed. Australian and New Zealand College of Anaesthetists; 2020.
   Google Scholar
• Daouphars M, Hervouët C-H, Bohn P, et al. Physicochemical stability of oxycodone-ketamine solutions in polypropylene syringe and polyvinyl chloride bag for patient-controlled analgesia use. Eur J Hosp Pharm. 2018;25(4):214–217. doi:10.1136/ejhpharm-2016-000965
   PubMedGoogle Scholar
• Pleasance S, Hines S. Compatibility of an injectable high strength oxycodone formulation with typical diluents, syringes, tubings, infusion bags and drugs for potential co-administration. EJHP Pract. 2009;15:1.
   Google Scholar
• Management of Peripheral Intravenous Catheters Clinical Care Standard. Australian commission on safety and quality in health care; 2023. Available from: https://www.safetyandquality.gov.au/standards/clinical-care-standards/management-peripheral-intravenous-catheters-clinical-care-standard. Accessed September 1, 2023.
   Google Scholar
• Guanche-Sicilia A, Sánchez-Gómez MB, Castro-Peraza ME, Rodríguez-Gómez J, Gómez-Salgado J, Duarte-Clíments G. Prevention and treatment of phlebitis secondary to the insertion of a peripheral venous catheter: a scoping review from a nursing perspective. Healthcare. 2021;9(5). doi:10.3390/healthcare9050611
   Web of Science ®Google Scholar
• Bardin C, Astier A, Vulto A, et al. Guidelines for the practical stability studies of anticancer drugs: a European consensus conference. Eur J Hosp Pharm Sci Pract. 2012;19(3):278. doi:10.1136/ejhpharm-2012-000112
   Google Scholar
• Bardin C, Astier A, Vulto A, et al. Guidelines for the practical stability studies of anticancer drugs: a European consensus conference. Ann Pharm Fr. 2011;69(4):221–231. doi:10.1136/ejhpharm-2012-000112
   PubMedGoogle Scholar
• Kleinlein M, Marschler S, Neininger MP, Hoeckel M, Bertsche T. Y‐site administration of electrolyte solutions and injectable Acetaminophen—a physical compatibility study with combinations frequently used in pediatric intensive care and anesthesia. Pediatr Anesthesia. 2023;33(1):69–78. doi:10.1111/pan.14569
   PubMed Web of Science ®Google Scholar
• Juan EP, Palau MM, Cerdá SA, Rubert MA, Nicolau BR. Compatibilité physique de médicaments administrés dans l’unité de soins intensifs. Pharmactuel. 2015;48(3):146–152.
   Google Scholar
• Evidence sources: management of peripheral intravenous catheters clinical care standard Australian Commission on safety and quality in health care. Available from: https://www.safetyandquality.gov.au/sites/default/files/2021-05/evidence_sources_-_management_of_peripheral_intravenous_catheters_clinical_care_standard.pdf. Accessed March 3, 2024.
   Google Scholar
• Lao GC, Reyes MR, Turet JR, Dot MP, Muner DS, Cabezas CL. Compatibility of drugs administered as Y-site infusion in intensive care units: a systematic review. Med Intensiva. 2020;44(2):80–87. doi:10.1016/j.medin.2018.08.004
   PubMed Web of Science ®Google Scholar
• Glassford NJ, French CJ, Bailey M, Martensson J, Eastwood GM, Bellomo R. Changes in intravenous fluid use patterns in Australia and New Zealand: evidence of research translating into practice. Crit Care Resuscitation. 2016;18(2):78–88. doi:10.1016/S1441-2772(23)01009-8
   PubMed Web of Science ®Google Scholar
• Trissel LA. Handbook on injectable drugs. In: Handbook on Injectable Drugs. ASHP; 2007:1720.
   Google Scholar
• Paes GO, Moreira SO, Moreira MB, Martins TG. Drug incompatibility in the ICU: review of implications in nursing practice. Rev Eletrôn Enferm. 2017;19:a20.
   Google Scholar
• D’Huart E, Vigneron J, Demoré B. Physical compatibility of intravenous drugs commonly used in intensive care units: an observational study and physical compatibility laboratory tests on anti-infective drugs. Pharm Technol Hosp Pharm. 2019;4(1):29–40. doi:10.1515/pthp-2019-0005
   Google Scholar
• Kanji S, Lam J, Johanson C, et al. Systematic review of physical and chemical compatibility of commonly used medications administered by continuous infusion in intensive care units. Crit Care Med. 2010;38(9):1890–1898. doi:10.1097/CCM.0b013e3181e8adcc
   PubMed Web of Science ®Google Scholar
• Kim YS, Lee CH, Kim AR, et al. Microbiological and physicochemical stability of fentanyl, oxycodone, hydromorphone, ketorolac, ramosetron, and ondansetron for intravenous patient-controlled analgesia: an in vitro study. Pain Physician. 2021;24(6):E829.
   PubMed Web of Science ®Google Scholar
• South Australian Neonatal Medication Guidelines: intravenous medication compatibility chart. Department of Health, Government of South Australia. Available from: https://www.sahealth.sa.gov.au/wps/wcm/connect/593fd13a-4f41-4bf9-af01-ae686f1e59ed/IV+Compatibility+in+Neonates_Neo_v3_0.pdf?MOD=AJPERES&CACHEID=ROOTWORKSPACE-593fd13a-4f41-4bf9-af01-ae686f1e59ed-ocQIQkC. Accessed March 11, 2024.
   Google Scholar
• Critical care intravenous drug administration guide. St George’s Healthcare. Available from: www.gicu.sgul.ac.uk/teaching/resources/pharmacology-and-toxicology/files/itu_IV_guide_-_2008_update_v2.pdf. Accessed March 11, 2024.
   Google Scholar
• Lexicomp trissels IV compatibility databases. Wolters Kluwer; 2023. Available from: https://www.wolterskluwer.com/en/solutions/lexicomp/resources/lexicomp-user-academy-old/trissels-iv-compatibility-databases. Accessed September 8, 2023.
   Google Scholar
• Garimella V, Cellini C. Postoperative pain control. Clin Colon Rectal Surg. 2013;26(3):191–196. doi:10.1055/s-0033-1351138
   PubMed Web of Science ®Google Scholar
• Kehlet H, Holte K. Effect of postoperative analgesia on surgical outcome. Br J Anaesth. 2001;87(1):62–72. doi:10.1093/bja/87.1.62
   PubMed Web of Science ®Google Scholar
• Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367(9522):1618–1625. doi:10.1016/s0140-6736(06)68700-x
   PubMed Web of Science ®Google Scholar
• McCarthy K, Avent M. Oral or intravenous antibiotics? Austr Prescr. 2020;43(2):45. doi:10.18773/austprescr.2020.008
   PubMed Web of Science ®Google Scholar
• McMullan BJ, Andresen D, Blyth CC, et al. Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines. Lancet Infect Dis. 2016;16(8):e139–e152.
   PubMed Web of Science ®Google Scholar
• Gai N, Naser B, Hanley J, Peliowski A, Hayes J, Aoyama K. A practical guide to acute pain management in children. J Anesth. 2020;34(3):421–433. doi:10.1007/s00540-020-02767-x
   PubMed Web of Science ®Google Scholar
• Holliday MA, Segar WE. The maintenance need for water in parenteral fluid therapy. Pediatrics. 1957;19(5):823–832. doi:10.1542/peds.19.5.823
   PubMed Web of Science ®Google Scholar
• Bruck E, Aceto T Jr, Lowe CU. Intravenous fluid therapy for infants and children. Physiologic principles and a practical regimen with examples of application. Pediatrics. 1960;25:496–516. doi:10.1542/peds.25.3.496
   PubMed Web of Science ®Google Scholar
• Nemec K, Kopelent-Frank H, Greif R. Standardization of infusion solutions to reduce the risk of incompatibility. Am J Health Syst Pharm. 2008;65(17):1648–1654. doi:10.2146/ajhp070471
   PubMed Web of Science ®Google Scholar
• Staven V, Wang S, Grønlie I, Tho I. Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs. Nutr J. 2016;15(1):29. doi:10.1186/s12937-016-0149-x
   PubMedGoogle Scholar
• Kufel WD, Miller CD, Johnson PR, Reid K, Zahra JJ, Seabury RW. Y-site incompatibility between premix concentrations of vancomycin and piperacillin-tazobactam: do current compatibility testing methodologies tell the whole story? Hosp Pharm. 2017;52(2):132–137. doi:10.1310/hpj5202-132
   PubMedGoogle Scholar
• Trissel LA, Martinez JF. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection. Am J Hosp Pharm. 1994;51(4):495–499.
   PubMedGoogle Scholar